je.st
news
Home
› Oncodesign Biotechnology And Bristol-Myers Squibb Enter Into Strategic Drug Discovery Collaboration
Oncodesign Biotechnology And Bristol-Myers Squibb Enter Into Strategic Drug Discovery Collaboration
2016-01-06 06:00:34| drugdiscoveryonline Home Page
ONCODESIGN (Alternext – ALONC), a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight cancer and other serious illnesses with no known effective treatment, recently announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds
Tags: enter
drug
collaboration
strategic
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||